INR 7942.15
(0.65%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 8.59 Billion INR | -7.31% |
2022 | 9.27 Billion INR | 22.38% |
2021 | 7.57 Billion INR | 24.99% |
2020 | 6.06 Billion INR | 37.61% |
2019 | 4.4 Billion INR | 1.97% |
2018 | 4.32 Billion INR | -16.08% |
2017 | 5.14 Billion INR | 3.41% |
2016 | 4.97 Billion INR | 2.05% |
2015 | 4.87 Billion INR | 19.35% |
2014 | 4.08 Billion INR | -0.45% |
2013 | 4.1 Billion INR | 5.34% |
2012 | 3.89 Billion INR | -8.09% |
2011 | 4.24 Billion INR | 82.16% |
2010 | 2.32 Billion INR | -11.22% |
2009 | 2.62 Billion INR | 68.64% |
2008 | 1.55 Billion INR | -15.76% |
2007 | 1.84 Billion INR | 0.0% |
2005 | 1.27 Billion INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q4 | 8.59 Billion INR | 0.0% |
2023 Q2 | 7.8 Billion INR | 0.0% |
2023 FY | 8.59 Billion INR | -7.31% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2022 Q2 | 8.25 Billion INR | 0.0% |
2022 FY | 9.27 Billion INR | 22.38% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 9.27 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 6.93 Billion INR | 0.0% |
2021 Q4 | 7.57 Billion INR | 0.0% |
2021 FY | 7.57 Billion INR | 24.99% |
2020 Q2 | 6.38 Billion INR | 0.0% |
2020 FY | 6.06 Billion INR | 37.61% |
2020 Q3 | - INR | -100.0% |
2020 Q1 | - INR | -100.0% |
2020 Q4 | 6.06 Billion INR | 0.0% |
2019 FY | 4.4 Billion INR | 1.97% |
2019 Q2 | 5.02 Billion INR | 0.0% |
2019 Q4 | 4.4 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2018 Q4 | 4.32 Billion INR | 0.0% |
2018 FY | 4.32 Billion INR | -16.08% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 6.38 Billion INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 Q1 | - INR | -100.0% |
2017 FY | 5.14 Billion INR | 3.41% |
2017 Q4 | 5.14 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q2 | 5.15 Billion INR | 0.0% |
2016 Q2 | 4.46 Billion INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q4 | 4.97 Billion INR | 0.0% |
2016 FY | 4.97 Billion INR | 2.05% |
2016 Q1 | - INR | -100.0% |
2015 FY | 4.87 Billion INR | 19.35% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 4.33 Billion INR | 0.0% |
2015 Q4 | 4.87 Billion INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2014 FY | 4.08 Billion INR | -0.45% |
2014 Q4 | 4.08 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q2 | 3.56 Billion INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2013 Q2 | 3.06 Billion INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2013 Q4 | 4.1 Billion INR | 0.0% |
2013 FY | 4.1 Billion INR | 5.34% |
2012 Q2 | 3.53 Billion INR | 0.0% |
2012 Q4 | 3.89 Billion INR | 0.0% |
2012 Q3 | - INR | -100.0% |
2012 FY | 3.89 Billion INR | -8.09% |
2011 Q4 | 4.24 Billion INR | 0.0% |
2011 FY | 4.24 Billion INR | 82.16% |
2010 Q4 | 2.32 Billion INR | 0.0% |
2010 FY | 2.32 Billion INR | -11.22% |
2009 FY | 2.62 Billion INR | 68.64% |
2008 FY | 1.55 Billion INR | -15.76% |
2007 FY | 1.84 Billion INR | 0.0% |
2005 FY | 1.27 Billion INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ador Multiproducts Limited | 28.52 Million INR | -30027.594% |
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -681.486% |
Bajaj Consumer Care Limited | 1.53 Billion INR | -461.748% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | 34.995% |
Cupid Limited | 186.52 Million INR | -4507.829% |
Dabur India Limited | 48.19 Billion INR | 82.167% |
Emami Limited | 8.21 Billion INR | -4.561% |
Godrej Consumer Products Limited | 58.97 Billion INR | 85.426% |
Hindustan Unilever Limited | 270.76 Billion INR | 96.826% |
Hipolin Limited | 48.57 Million INR | -17594.604% |
Honasa Consumer Limited | 5.36 Billion INR | -60.12% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | -3063.272% |
Jyothy Labs Limited | 5.9 Billion INR | -45.497% |
Kaya Limited | 5.22 Billion INR | -64.576% |
Marico Limited | 32.52 Billion INR | 73.571% |
N.K Industries Limited | 22.4 Billion INR | 61.635% |
PAOS INDUSTRIES LIMITED | 163.96 Million INR | -5141.723% |
Paramount Cosmetics (India) Limited | 205.72 Million INR | -4077.81% |
Pee Cee Cosma Sope Limited | 80.17 Million INR | -10619.515% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 20.69% |